London, SW1E6AU, United Kingdom
NCT Number: NCT02147093
CLARITI (TM) 1-Day Multifocal Contact Lenses Performance and Acceptance Evaluation
A comparative evaluation of a newly marketed multifocal contact lens with a single vision contact lens when used with near vision spectacles. The evaluation was to quantify the difference between the two test corrections.
Looking for future studies?
Notify MeKey information
Conditions
Age range
45 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Age 45 years or more
- Spectacle or soft contact lens wearer
- Refraction: best sphere (corrected for back vertex distance) -6.00 Diopters (D) to +4.00 D; Astigmatism - 0.00 D to -0.75 D; Near addition for 40 cm; Medium Add: +1.50 D to +2.00 D; High Add: +2.25 D to +2.50 D
- Best spectacle corrected visual acuity of 6/9 or better in each eye
- Willingness to adhere to the instructions set forth in the clinical protocol
- Signature of the subject Informed Consent form after review of Information to Participant document.
Exclusion criteria
- Systemic or ocular allergies which might interfere with contact lens wear
- Systemic disease which might interfere with contact lens wear
- Ocular disease which might interfere with contact lens wear (e.g. hypothesia, insufficient lacrimal secretion)
- Use of medication which might interfere with contact lens wear
- Active ocular infection
- Use of ocular medication
- Significant ocular anomaly
- Presence of two or more corneal scars in either eye
- Monovision contact lens wearers
- Pregnancy or lactation
- Any medical condition that might be prejudicial to the study
- Participants non-able to give consent or from a vulnerable group
- Infectious disease (for example, hepatitis, tuberculosis, etc.) or a contagious immunosuppressive disease (such as HIV, AIDS, etc.)
- Employees or family member of the investigational clinic (e.g. investigator, coordinator, technician)
Treatment and study plan
Test (multi-focal)
Devicecontact lens was to be worn a daily wear.
Other names: Clariti 1 Day, filcon II 3
Control (Sphere)
Devicecontact lens was to be worn a daily wear with spectacles
Other names: filcon II 3
Primary outcomes
-
Distance LogMAR Visual Acuity
Time frame: 7 days post wear
Distance time controlled LogMAR (Logarithm of the Minimum Angle of Resolution) Visual Acuity was carried out binocularly, at 4m (meter) under 250 cd/m^2 and 2.5 cd/m^2 (candela per square meter) luminance. The test was presented under the two conditions; High luminance (250 cd/m^2) High Contrast (90%) & Low Contrast (10%) and Low Luminance (2.5 cd/m^2) High Contrast (90%)
-
Near LogMAR Visual Acuity
Time frame: 7 days post wear
Near time controlled LogMAR Visual Acuity was carried out binocularly, at 4cm under 250 cd/m^2 and 50 cd/m^2 luminance. The test was presented on under the two conditions; High Luminance (250cd/m^2) High Contrast (90%) & Low Contrast (10%) and Low Luminance (50cd/m^2) High Contrast (90%)
Sponsors and collaborators
Lead sponsor
Johnson & Johnson Vision Care, Inc.
Industry
Registry information
Important dates
- Study start
- 2014
- Primary completion
- 2014
- Study completion
- 2014
- First posted
- May 26, 2014
- Registry last updated
- Jun 19, 2018
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Evaluation Of Patient Satisfaction And Quality Of Vision After EDOF Or Trifocal IOL Implantation
NCT07295119
Cataract, Eye Diseases
Verona, Italy
View Trial DetailsVisual Quality and Performance of Eyes With Asqelio™ EDoF Toric Lenses
NCT06707545
Cataract, Eye Diseases
Córdoba, Cordoba, Spain
View Trial DetailsThe Purpose is to Evaluate Visual Acuity for Distance, Intermediate and Near and Additionally Contrast Sensitivity at 25% and 10% of Illumination After Implantation of Trifocal IOL, Extended Range of Vision IOL, Bifocal IOL With Low Addition and Monofocal IOL
NCT07008768
Cataract, Eye Diseases
Zagreb, Croatia
View Trial DetailsPresbyopic Wear Experience With Multifocal Lenses Compared to Single Vision Lenses and Reading Glasses
NCT07218731
Eye Diseases, Presbyopia
Columbus, Ohio, United States
View Trial Details